Analysis and validation of host cell protein kits
5 Sept 2022
In this video, Mohamed Shaker, Lead Analytical Scientist, Fast Track, Cytiva, discusses why regulatory bodies are getting strict about host cell protein (HCP) contaminants in therapeutics and how analysis of HCP contaminants is performed. Plus learn about 2D-DIBE™ an accurate and reliable coverage assay for anti-HCP ELISA antibodies.
About the company
Cytiva
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex and Xuri. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients. Visit cytiva.com for more.
